Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
27 Oct 2016 07:00 AM
RNS
Notification of Major Interest in Shares
27 Oct 2016 07:00 AM
RNS
Sale of Innovenn UK Limited and Result of GM
12 Oct 2016 07:00 AM
RNS
Directors' Dealings
04 Oct 2016 07:00 AM
RNS
Sale of Innovenn & Notice of General Meeting
28 Sep 2016 07:00 AM
RNS
Half-year Report
23 Sep 2016 07:00 AM
RNS
Exercise of Share Options
22 Sep 2016 07:00 AM
RNS
Half-year Report
22 Sep 2016 07:00 AM
RNS
Appointment of Non Executive Director
21 Sep 2016 07:00 AM
RNS
Trading Update
13 Sep 2016 07:00 AM
RNS
Directorate Change
08 Sep 2016 07:00 AM
RNS
Notification of Major Interest in Shares
02 Sep 2016 07:00 AM
RNS
hVIVO Landmark Asthma Study Underway
24 Aug 2016 07:00 AM
RNS
Notice of Results
04 Aug 2016 07:00 AM
RNS
Directors' Dealings
03 Aug 2016 07:00 AM
RNS
Contract wins
12 Jul 2016 12:45 PM
RNS
Notification of Major Interest in Shares
30 Jun 2016 12:18 PM
RNS
Result of AGM
30 Jun 2016 07:00 AM
RNS
AGM Statement
20 Jun 2016 04:24 PM
RNS
Shareholder notification
14 Jun 2016 12:00 PM
RNS
Favourable results for PrEP Biopharm's Flu Study
10 Jun 2016 11:05 AM
RNS
Posting of Annual Report and Notice of AGM
24 May 2016 07:00 AM
RNS
David Norwood Lock-in Deed
23 May 2016 12:00 PM
RNS
Result of AGM
10 May 2016 07:00 AM
RNS
Final Results
28 Apr 2016 02:05 PM
RNS
2015 Annual Report and Financial Statements
27 Apr 2016 07:00 AM
RNS
Notification of Major Interest in Shares
25 Apr 2016 07:00 AM
RNS
Initial results for PrEP Biopharm's Flu study
22 Apr 2016 07:00 AM
RNS
Joint Venture Investment with the SEEK Group
21 Apr 2016 11:43 AM
RNS
Notification of Major Interest in Shares
20 Apr 2016 07:01 AM
RNS
Board Changes
20 Apr 2016 07:00 AM
RNS
2015 Audited Preliminary Results
14 Apr 2016 07:00 AM
RNS
Directors' Dealings
24 Mar 2016 07:00 AM
RNS
Year End Update
16 Mar 2016 09:32 AM
RNS
Notification of Major Interest in Shares
13 Jan 2016 07:00 AM
RNS
ESM Schedule 1 update
13 Jan 2016 07:00 AM
RNS
ESM Appendix to Schedule 1 update
12 Jan 2016 07:00 AM
RNS
Contracts worth EUR 3.4m signed with US Biotech
08 Jan 2016 02:03 PM
RNS
Holding(s) in Company
08 Jan 2016 07:01 AM
RNS
Trading update
08 Jan 2016 07:00 AM
RNS
Directorate Change
06 Jan 2016 07:00 AM
RNS
Directors' Dealings
18 Dec 2015 07:00 AM
RNS
Notification of Major Interest in Shares
17 Dec 2015 02:00 PM
RNS
Notification of Major Interest in Shares
17 Dec 2015 07:00 AM
RNS
Notification of Major Interest in Shares
15 Dec 2015 02:00 PM
RNS
Result of General Meeting
11 Dec 2015 07:00 AM
RNS
Change of Adviser
11 Dec 2015 07:00 AM
RNS
ESM Pre-Admission Announcement
11 Dec 2015 07:00 AM
RNS
Appendix to Schedule 1 announcement
30 Nov 2015 07:00 AM
RNS
Notification of Major Interest in Shares
26 Nov 2015 07:00 AM
RNS
Conditional Placing to raise £20.5 million

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings